BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 35141222)

  • 1. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
    Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
    Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
    [No Abstract]   [Full Text] [Related]  

  • 2. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 5. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8
    Ge J; Liu SL; Zheng JX; Shi Y; Shao Y; Duan YJ; Huang R; Yang LJ; Yang T
    Transl Oncol; 2023 Aug; 34():101683. PubMed ID: 37224767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
    Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
    Front Immunol; 2021; 12():781221. PubMed ID: 34950145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
    Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
    J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis reveals TSPEAR as a prognostic biomarker in colorectal cancer.
    Xue D; Peng H; Li Z; Xu J; Ma H; Dang Y; Li F; Wang G; Sun Q
    J Cancer; 2024; 15(3):809-824. PubMed ID: 38213725
    [No Abstract]   [Full Text] [Related]  

  • 14. Unraveling TIMP1: a multifaceted biomarker in colorectal cancer.
    Qiu X; Quan G; Ou W; Wang P; Huang X; Li X; Shen Y; Yang W; Wang J; Wu X
    Front Genet; 2023; 14():1265137. PubMed ID: 37842645
    [No Abstract]   [Full Text] [Related]  

  • 15. CRYAB predicts clinical prognosis and is associated with immunocyte infiltration in colorectal cancer.
    Deng J; Chen X; Zhan T; Chen M; Yan X; Huang X
    PeerJ; 2021; 9():e12578. PubMed ID: 34966587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
    Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
    Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer.
    Shang Y; Zhang Y; Liu J; Chen L; Yang X; Zhu Z; Li D; Deng Y; Zhou Z; Lu B; Fu CG
    J Cancer; 2022; 13(2):653-668. PubMed ID: 35069909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
    Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
    Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
    Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
    J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.